Transactions
License to
2018
License to
2018
Sale of Royalties to
2018
License To
December 2017
Sale to
2017
Fairness Opinion
2017
Global license
Gaboxadol from
March 2015
$50,000,000 Initial Public Offering / Co-Manager
June 2014
Advisor
February 2014
Global License to
January 2013
$5 Million PIPE
Co-Placement Agent
April 2013
Global Licensing of
IgA Protease
October 2012
Global Licensing of
HuGAL-F2
September 2012
Global Licensing of
HuGAL-FR21
December 2011
Advisor
2010-2011
Advisor
2009-2011
Global license to
May 2010
Advisor
2010
Advisor
2010
$35 Million PIPE
Lead Placement Agent
October 2009
Advisor
2009
Advisor
2009
Advisor
2008-2009
Sale to
May 2008
